IRIS
CANNAVO', Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.102
EU - Europa 5.189
AS - Asia 1.293
SA - Sud America 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 12.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.084
IE - Irlanda 1.528
SE - Svezia 1.183
CN - Cina 909
IT - Italia 705
UA - Ucraina 391
PL - Polonia 356
DE - Germania 328
FI - Finlandia 241
SG - Singapore 226
GB - Regno Unito 205
FR - Francia 115
IN - India 72
VN - Vietnam 56
BE - Belgio 38
RU - Federazione Russa 26
CZ - Repubblica Ceca 23
AT - Austria 18
CA - Canada 12
JP - Giappone 8
AU - Australia 6
NL - Olanda 6
CL - Cile 4
ES - Italia 4
EU - Europa 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
LK - Sri Lanka 2
MD - Moldavia 2
MX - Messico 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
CO - Colombia 1
HK - Hong Kong 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 12.608
Salva come PNG Salva come JPEG
Città #
Dublin 1.527
Chandler 1.264
Jacksonville 915
Nyköping 697
Beijing 370
Warsaw 355
Ashburn 326
Princeton 294
Dearborn 274
Messina 261
Medford 236
Cambridge 228
Des Moines 206
Singapore 145
Ann Arbor 136
Boardman 131
Lancaster 110
Wilmington 88
New York 77
Shenyang 71
Jinan 63
San Mateo 60
Los Angeles 57
Nanjing 57
Dong Ket 56
Hyderabad 44
Tianjin 44
Woodbridge 42
Haikou 39
Seattle 39
Brussels 35
Hebei 35
Helsinki 34
Bremen 30
Hangzhou 29
Munich 29
Nanchang 26
Ningbo 26
Zhengzhou 26
Houston 25
Catania 23
Rome 23
Pune 21
Turin 21
Guangzhou 19
Falls Church 18
Taizhou 17
Vienna 16
Washington 16
Fuzhou 14
Strasbourg 13
Clearwater 12
Brno 11
Changsha 10
Redmond 10
Milan 9
Norwalk 9
Lanzhou 8
Olomouc 8
Palermo 8
Carrara 7
Edinburgh 7
Jiaxing 7
Ottawa 7
Saint Petersburg 7
Fairfield 6
Lappeenranta 6
Reggio Calabria 6
Tappahannock 6
Auburn Hills 5
Bologna 5
Kunming 5
Sydney 5
Brescia 4
Genova 4
Greifswald 4
Las Vegas 4
Parma 4
Riva 4
Tokyo 4
Vittoria 4
Augusta 3
Capri Leone 3
Cluses 3
Floridia 3
Fremont 3
Kemerovo 3
London 3
Madrid 3
Marburg 3
Mumbai 3
Naples 3
Prineville 3
Ragusa 3
Reston 3
Siracusa 3
Taiyuan 3
Torino 3
Vicenza 3
Belgrade 2
Totale 8.960
Salva come PNG Salva come JPEG
Nome #
La chirurgia tiroidea transorale 145
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 102
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 101
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 101
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 98
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 92
Aggressive pituitary adenomas: the dark side of the moon 86
L’apoplessia ipofisaria: riconoscerla rapidamente e trattarla correttamente. 84
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 83
A 53-year-old woman with Cushing's disease and a pituitary tumor 79
Acromegaly is associated with increased cancer risk: a survey in Italy 78
Commentary on "Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas" 77
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 76
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 76
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 76
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 74
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 74
Acne ed irsutismo: patologie endocrine? 73
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 73
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 72
Increased prevalence of acromegaly in a highly polluted area. 70
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 70
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 70
Multidisciplinary management of pituitary apoplexy 69
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 67
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 66
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 66
Modificazione del pattern secretivo, dopo chirurgia, e dei marker proliferativi cellulari, dopo radioterapia (gamma-knife), in un corticotropinoma invasivo. 65
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. 64
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography 64
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 64
Markers di aterosclerosi precoce nei vasi carotidei e femorali in pazienti acromegalici 63
Predictive markers of recurrence in radically resected pituitary macroadenomas 63
Analisi dell'intervallo QT all'ECG di superficie in pazienti affetti da deficit primario di GH con e senza ipertrofia ventricolare sinistra 63
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 63
Thyroid nodules in growth hormone replaced patients. 63
Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella 62
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 62
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 62
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 62
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 62
XANTHOMA DISSEMINATUM WITH HYPOTHALAMUS-PITUITARY INFILTRATION AND PARTIAL HYPOPITUITARISM 61
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 61
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 61
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 61
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 60
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: a systematic review 60
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 60
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 59
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 59
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 59
Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline 58
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 58
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 58
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 58
Evaluation of myocardial fibrosis by imaging techniques in acromegaly. 57
Valutazione dell'asse ipotalamo-ipofisi-tiroide e del volume tiroideo in pazienti acromegalici 57
Atrial parasystole in left ventricular noncompaction: a morphofunctional study by echocardiography and magnetic resonance imaging. 57
Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea 56
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis. 56
Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. 55
Alterazioni della funzionalità tiroidea in pazienti con sindrome della sella vuota primaria 55
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 55
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 55
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 55
Oxidative stress as a key feature of autoimmune thyroiditis: an update 55
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 55
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 55
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 54
Therapy for the syndromes of GH excess 54
Subcutaneous lipoatrophy induced by long-term pegvisomant administration 54
TREATMENT OF PITUITARY TUMOURS BY CYBERKNIFE: PRELIMINARY DATA OF MIDDLE-TERM EFFECTIVENESS AND SAFETY 54
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 54
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 54
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. 53
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 53
A case of clinically silent acromegaly with erectile dysfunction. 53
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 53
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 53
Clinical presentation and outcome of pituitary adenomas in teenagers 53
Global epidemiology of acromegaly: A systematic review and meta-analysis 53
Twelve months of treatment with octreotide LAR reduces joint thickness in acromegaly 52
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 52
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 52
Effects of cyberknife radiotherapy treatment of pituitary adenomas 52
Linee di Consenso diagnostico-terapeutico: le iperprolattinemie 51
Modificazione dei parametri di rischio cardiovascolare durante trattamento sostitutivo prolungato con ormone della crescita 51
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 51
Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during thespontaneous remission of Cushing's disease. 51
Early-onset cerebellar ataxia, myoclonus and hypogonadism in a case of mitochondrial complex III deficiency treated with vitamins K3 and C 51
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 51
Gigantismo e acromegalia causati da microduplicazioni del locus Xp26 e da mutazione del gene GPR101 51
Dopamine D(2) receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. 50
Temozolomide-induced shrinkage of a pituitary carcinoma. 50
Mutazioni del gene USP8 che causano guadagno di funzione nella malattia di Cushing 50
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 50
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 50
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 50
Severe head trauma in patients with unexplained central hypothyroidism 49
DISSOCIATION BETWEEN IN VIVO (OCTREOSCAN) AND IN VITRO EXPRESSION OF SPECIFIC SOMATOSTATIN RECEPETORS AND RESPONSIVENESS TO SOMATOSTATIN ANALOGS (SSAs) TREATMENT IN A FSH-SECRETING PITIUTARY ADENOMA 49
Totale 6.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.990
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.383 0 0 12 100 16 296 210 172 42 252 265 18
2020/20212.046 165 34 420 119 164 345 160 164 136 162 72 105
2021/20221.716 15 219 31 98 50 23 87 76 41 205 243 628
2022/20234.733 400 365 205 392 323 482 90 297 1.872 48 199 60
2023/20241.210 111 215 99 109 111 216 20 105 4 66 7 147
2024/2025336 103 84 149 0 0 0 0 0 0 0 0 0
Totale 13.316